|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00035386 |
|
Date of registration:
|
02/05/2002 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy: A Pilot Study
|
|
Scientific title:
|
Trans-Right Ventricular Approach to Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy: A Pilot Feasibility Study |
|
Date of first enrolment:
|
April 2002 |
|
Target sample size:
|
12 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00035386 |
|
Study type:
|
Interventional |
|
Study design:
|
Endpoint Classification: Safety/Efficacy Study, Primary Purpose: Treatment
|
|
Phase:
|
Phase 2
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Key inclusion & exclusion criteria
|
INCLUSION CRITERIA:
Patients of either gender, aged 18-85 years.
Symptomatic patients receiving clinically indicated evaluation for cardiomyopathy and
found to have obstructive HCM.
LV outflow tract gradient greater than 30 mm Hg at rest by echocardiography or cardiac
catheterization.
EXCLUSION CRITERIA:
Positive pregnancy test.
Age minimum:
N/A
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Hypertrophic Cardiomyopathy
|
|
Intervention(s)
|
|
Procedure: trans-right ventricular alcohol septal ablation (TRVASA)
|
|
Secondary ID(s)
|
|
02-H-0125
|
|
020125
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|